Literature DB >> 1443021

Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity.

T N Fleming1, P E Runge, S T Charles.   

Abstract

Nine infants with posterior retinopathy of prematurity were treated by using the diode laser through an indirect ophthalmoscopic delivery system. Treatment was commenced as soon as plus disease (defined as tortuosity and dilation of posterior vessels) developed. We defined posterior retinopathy of prematurity as retinopathy of prematurity located in zone 1 (the limits of zone 1 are defined as twice the disk-fovea distance in all directions from the optic disk, that is, an arc of 60 degrees centered on the optic disk) or the posterior one half of zone 2 (zone 2 extends from the edge of zone 1 peripherally to a point tangential to the nasal ora serrata and around to an area near the temporal anatomic equator). Disease regressed in all eyes. These results are encouraging and represent an improvement over the results obtained by allowing these eyes to reach threshold (threshold disease is defined as 5 or more contiguous or 8 total clock hours of neovascularization in zone 1 or 2 in the presence of plus disease) before intervention.

Entities:  

Mesh:

Year:  1992        PMID: 1443021     DOI: 10.1016/s0002-9394(14)74488-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Diode laser treatment of posterior retinopathy of prematurity.

Authors:  R Axer-Siegel; M Snir; D Cotlear; A Maayan; R Frilling; I Rosenbaltt; D Weinberger; I Kremer; L Sirota
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Non-ophthalmologist screening for retinopathy of prematurity.

Authors:  R A Saunders; M L Donahue; J E Berland; E L Roberts; B Von Powers; P F Rust
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

Review 4.  Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?

Authors:  Andreas Stahl; Ann Hellstrom; Lois E H Smith
Journal:  Neonatology       Date:  2014-10-05       Impact factor: 4.035

5.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 6.  Retinopathy of prematurity.

Authors:  E Bossi; F Koerner
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

7.  Diode laser for retinopathy of prematurity--early outcome.

Authors:  M Goggin; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

8.  Diode laser photocoagulation for stage 3+ retinopathy of prematurity.

Authors:  V Seiberth; O Linderkamp; I Vardarli; M C Knorz; H Liesenhoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

9.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

10.  Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors.

Authors:  Vivek B Wani; Niranjan Kumar; Khalid Sabti; Seemant Raizada; Nabeel Rashwan; Mumtaz M Shukkur; Mohammed Harbi
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.